glp-1 medications in the workplace Ole Miss researchers study barriers to insurance coverage Transformation 2.0: The GLP-1 RAs

Key takeaways Population mortality By 2045, incretin-based drugs such as GLP-1s could reduce mortality in the US by 3.5% in a central scenario, 8.8% in an optimistic scenario, and 1.0% in a pessimistic scenario In the same central scenario, mortality could decrease by 2.0% in the UK, 2.6% in Canada and 1.4% in Hong Kong

Methods: Data were collected from 283 participants who underwent liver disease severity screening for potential inclusion into a clinical trial, focusing on demographics, liver biopsy results, and various fibrosis markers

The broad receptor activity of retatrutide means it influences multiple physiological systems beyond glucose and weight regulation

It is encouraged to discuss with your doctor the possibility of prescribing an equivalent and/or similar medication approved for weight loss by the FDA

Before you travel, take five minutes to check or ask your pharmacist about your specific medication's storage guidance